IP Library › Assignment 076134/0790
Patent Assignment
Reel/Frame 076134/0790

Security Interest

Recorded: 2026-09-24 Pages: 10
Assignor
THERAVANCE BIOPHARMA R&D IP, LLC
Executed: 2026-09-23
Assignee
U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
5065 WOOSTER ROAD, CINCINNATI, OHIO, 45226
Covered Properties (29)
Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
Patent: 7,629,336 →
Application: 11/371,512 →
Publication: US US20060205775A1
Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
Patent: 8,501,776 →
Application: 12/956,143 →
Publication: US US20110071190A1
Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
Patent: 7,288,657 →
Application: 11/077,433 →
Publication: US US20050203133A1
Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
Patent: 8,017,783 →
Application: 11/899,181 →
Publication: US US20080071088A1
Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
Application: 17/569,255 →
Publication: US US20220306579A1
Crystalline Forms of a Biphenyl Compound
Patent: 8,242,137 →
Application: 12/563,727 →
Publication: US US20100021395A1
Crystalline Forms of a Biphenyl Compound
Patent: 8,377,965 →
Application: 12/817,543 →
Publication: US US20100256185A1
Crystalline Freebase Forms of a Biphenyl Compound
Patent: 8,541,451 →
Application: 12/835,964 →
Publication: US US20110015163A1
Crystalline Freebase Forms of a Biphenyl Compound
Patent: 8,921,396 →
Application: 13/973,174 →
Publication: US US20130338191A1
Crystalline Freebase Forms of a Biphenyl Compound
Patent: 9,226,896 →
Application: 14/547,455 →
Publication: US US20150164796A1
Crystalline Freebase Forms of a Biphenyl Compound
Patent: 9,415,041 →
Application: 14/955,515 →
Publication: US US20160143897A1
Crystalline Freebase Forms of a Biphenyl Compound
Patent: 9,765,028 →
Application: 15/206,877 →
Publication: US US20170081283A1
Crystalline Freebase Forms of a Biphenyl Compound
Application: 15/677,264 →
Publication: US US20180186740A1
Crystalline Freebase Forms of a Biphenyl Compound
Application: 16/130,079 →
Publication: US US20190248743A1
Crystalline Freebase Forms of a Biphenyl Compound
Application: 16/715,225 →
Publication: US US20200308116A1
Crystalline Freebase Forms of a Biphenyl Compound
Application: 17/301,820 →
Publication: US US20220009890A1
Crystalline Freebase Forms of a Biphenyl Compound
Application: 17/841,567 →
Publication: US US20220306580A1
Crystalline Freebase Forms of a Biphenyl Compound
Application: 18/199,812 →
Publication: US US20230303492A1
Crystalline Freebase Forms of a Biphenyl Compound
Application: 18/762,102 →
Publication: US US20250179019A1
Process for Preparing a Biphenyl-2-Ylcarbamic Acid
Patent: 8,754,225 →
Application: 13/173,274 →
Publication: US US20120016130A1
Process for Preparing a Biphenyl-2-Ylcarbamic Acid
Patent: 9,035,061 →
Application: 14/090,211 →
Publication: US US20140121378A1
Methods for Treating Chronic Obstructive Pulmonary Disease
Application: 16/555,216 →
Publication: US US20200069667A1
Methods for Treating Chronic Obstructive Pulmonary Disease
Application: 18/137,919 →
Publication: US US20230255952A1
Methods for Treating Chronic Obstructive Pulmonary Disease
Application: 18/137,922 →
Publication: US US20230330075A1
Processes for Preparing Revefenacin and Compositions Comprising the Same
Application: 18/496,404 →
Publication: US US20250136550A1
Crystalline Forms of a Biphenyl Compound
Application: 16/744,557 →
Publication: US US20200317641A1
Crystalline Forms of a Biphenyl Compound
Application: 15/486,796 →
Publication: US US20180051004A1
Crystalline Forms of a Biphenyl Compound
Patent: 9,249,099 →
Application: 14/552,893 →
Publication: US US20150152054A1
Crystalline Forms of a Biphenyl Compound
Patent: 9,656,993 →
Application: 14/974,980 →
Publication: US US20160168120A1
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 10, 2005
From: MAMMEN, MATHAI; JI, YU-HUA; MU, YONGQI; HUSFELD, CRAIG
To: THERAVANCE, INC.
Reel/Frame 016375/0023 →
Assignment of Assignor's Interest Mar 9, 2006
From: JI, YU-HUA; HUSFELD, CRAIG; LI, LI; MAMMEN, MATHAI
To: THERAVANCE, INC.
Reel/Frame 017667/0819 →
Assignment of Assignor's Interest Jul 14, 2010
From: GLAXO GROUP LIMITED
To: THERAVANCE, INC.
Reel/Frame 024685/0069 →
Assignment of Assignor's Interest Jul 14, 2010
From: WOOLLAM, GRAHAME; GLAXOSMITHKLINE SERVICES UNLIMITED; GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LIMITED
To: GLAXO GROUP LIMITED
Reel/Frame 024685/0045 →
Assignment of Assignor's Interest Jun 3, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA R&D IP, LLC
Reel/Frame 033118/0499 →
Assignment of Assignor's Interest Jun 3, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA R&D IP, LLC
Reel/Frame 033127/0174 →
Assignment of Assignor's Interest Jun 4, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA R&D IP, LLC
Reel/Frame 033123/0478 →
Assignment of Assignor's Interest Jun 11, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA R&D IP, LLC
Reel/Frame 033163/0133 →